Evidence map›Paper›PMID 29514648›Full record

ArticleRespiratory research2018

Long-term smoking alters abundance of over half of the proteome in bronchoalveolar lavage cell in smokers with normal spirometry, with effects on molecular pathways associated with COPD.

Mingxing Yang, Maxie Kohler, Tina Heyder, Helena Forsslund, Hilde K Garberg, Reza Karimi, Johan Grunewald, Frode S Berven, C Magnus Sköld, Åsa M Wheelock

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Respiratory research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02627872 (Clinical & Systems Medicine Investigations of Smoking-related Chronic Obstructive Pulmonary Disease), which is not on this map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02627872 active not recruitingnot on this map

Clinical & Systems Medicine Investigations of Smoking-related Chronic Obstructive Pulmonary Disease

TypeobservationalSponsorKarolinska InstitutetRan2007 to 2030Enrolled120ConditionsChronic Obstructive Pulmonary Disease, Emphysema, Chronic Bronchitis, Chronic Airways Obstruction
3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Prognostic Biomarkers Based on Proteomic Technology in COPD: A Recent Review.International journal of chronic obstructive pulmonary disease · 2023
    Review
  12. Article
  13. Article
  14. Article
  15. Urinary Leukotriene EAmerican journal of respiratory and critical care medicine · 2021
    Observational
  16. Associations between Genetically Predicted Blood Protein Biomarkers and Pancreatic Cancer Risk.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2020
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Mingxing YangDepartment of Medicine Solna & Center for Molecular Medicine, Respiratory Medicine Unit, Lung Research Lab L4:01, Karolinska Institutet, 171 76, Stockholm, Sweden. 2002ymx02@gmail.com.ORCID 0000-0003-4286-2226
Maxie KohlerDepartment of Medicine Solna & Center for Molecular Medicine, Respiratory Medicine Unit, Lung Research Lab L4:01, Karolinska Institutet, 171 76, Stockholm, Sweden.
Tina HeyderDepartment of Medicine Solna & Center for Molecular Medicine, Respiratory Medicine Unit, Lung Research Lab L4:01, Karolinska Institutet, 171 76, Stockholm, Sweden.
Helena ForsslundDepartment of Medicine Solna & Center for Molecular Medicine, Respiratory Medicine Unit, Lung Research Lab L4:01, Karolinska Institutet, 171 76, Stockholm, Sweden.
Hilde K GarbergDepartment of Biomedicine, Proteomics Unit (PROBE), University of Bergen, Bergen, Norway.
Reza KarimiDepartment of Medicine Solna & Center for Molecular Medicine, Respiratory Medicine Unit, Lung Research Lab L4:01, Karolinska Institutet, 171 76, Stockholm, Sweden.
Johan GrunewaldDepartment of Medicine Solna & Center for Molecular Medicine, Respiratory Medicine Unit, Lung Research Lab L4:01, Karolinska Institutet, 171 76, Stockholm, Sweden.
Frode S BervenDepartment of Biomedicine, Proteomics Unit (PROBE), University of Bergen, Bergen, Norway.
C Magnus SköldDepartment of Medicine Solna & Center for Molecular Medicine, Respiratory Medicine Unit, Lung Research Lab L4:01, Karolinska Institutet, 171 76, Stockholm, Sweden.
Åsa M WheelockDepartment of Medicine Solna & Center for Molecular Medicine, Respiratory Medicine Unit, Lung Research Lab L4:01, Karolinska Institutet, 171 76, Stockholm, Sweden. asa.wheelock@ki.se.
Karolinska Institutet · SEUniversity of Bergen · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSmoking represents a significant risk factor for many chronic inflammatory diseases, including chronic obstructive pulmonary disease (COPD).

methodsTo identify dysregulation of specific proteins and pathways in bronchoalveolar lavage (BAL) cells associated with smoking, isobaric tags for relative and absolute quantitation (iTRAQ)-based shotgun proteomics analyses were performed on BAL cells from healthy never-smokers and smokers with normal lung function from the Karolinska COSMIC cohort. Multivariate statistical modeling, multivariate correlations with clinical data, and pathway enrichment analysis were performed.

resultsSmoking exerted a significant impact on the BAL cell proteome, with more than 500 proteins representing 15 molecular pathways altered due to smoking. The majority of these alterations occurred in a gender-independent manner. The phagosomal- and leukocyte trans endothelial migration (LTM) pathways significantly correlated with FEV

conclusionThe significant correlations of proteins in the phagosome- and LTM pathways with activated cytotoxic T-cells (CD69+) and the level of airway obstruction (FEV

trial registrationClinicalTrials.gov identifier NCT02627872 ; Retrospectively registered on December 9, 2015.

Indexed as

Bronchoalveolar Lavage FluidSmokersAgedCohort StudiesFemaleHumansMaleMiddle AgedProteomePulmonary Disease, Chronic ObstructiveSmokingSpirometryTime FactorsProteomeBronchoalveolar lavageCOPDInflammationProteomicsSmoking

Identifiers

PMID29514648
PMCPMC5842534
OpenAlexW2790483441

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.